Skip to main content
India Glycols Ltd logo

India Glycols Ltd — Investor Relations & Filings

Ticker · INDIAGLYCO ISIN · INE560A01023 LEI · 3358002YVDZUMPZLN823 BSE.NS Manufacturing
Filings indexed 1,575 across all filing types
Latest filing 2023-02-08 Regulatory Filings
Country IN India
Listing BSE.NS INDIAGLYCO

About India Glycols Ltd

https://www.indiaglycols.com/

India Glycols Ltd is a pioneer in the manufacturing of green technology-based chemicals. The company specializes in producing bio-based glycols, including monoethylene glycol (MEG), diethylene glycol (DEG), and triethylene glycol (TEG), utilizing renewable feedstock such as molasses. Its product portfolio extends to ethylene oxide derivatives, surfactants, and performance chemicals tailored for diverse applications in textiles, personal care, and oil and gas. Additionally, the company operates in the natural gums, industrial gases, and nutraceuticals sectors. IGL is recognized for its commitment to sustainable chemistry, being the first globally to commercialize the production of ethylene oxide and glycols from bio-ethanol. Its operations also include the production of extra neutral alcohol and high-quality spirits, serving both industrial and consumer markets with a focus on eco-friendly processes.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about an upcoming Q3FY23 Results Conference Call scheduled for February 10, 2023. It includes details about the call, participants, and access information. There is no actual financial data or results presented in the document, only an announcement of the event. The document length is 2822 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript announcement or invitation, but since it does not contain the transcript itself, it is an announcement related to a conference call. Given the classification options, the closest fit is Call Transcript (CT) as it pertains to the conference call event, but since it is only an invitation and not the transcript, the best classification is Regulatory Filings (RNS) as a general regulatory announcement about the call. However, the instructions specify that announcements of calls are not transcripts, so the correct classification is Regulatory Filings (RNS).
2023-02-08 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Results ....
Call Transcript Classification · 85% confidence The document is a notification about an upcoming Q3FY23 Results Conference Call scheduled for February 10, 2023. It includes details about the call, participants, and access information. There is no actual financial data or analysis presented in the document, only an announcement of the event. The document length is 2822 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript announcement or invitation, but since it is only an invitation and not the transcript itself, it fits best under Regulatory Filings (RNS) as a general regulatory announcement. However, given the specific nature of the announcement about a conference call, the most appropriate classification is Call Transcript (CT) as it relates directly to the earnings call event, even though it is an invitation rather than the transcript itself. The confidence is high due to clear mention of the conference call and no financial data present.
2023-02-08 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Results ....
Call Transcript Classification · 95% confidence The document is a notification about an upcoming Q3FY23 Results Conference Call scheduled for February 10, 2023. It includes details about the call, participants, and access information but does not contain any financial results or substantive financial data itself. The document is relatively short (2822 characters) and serves as an announcement for the conference call rather than the transcript or report of the results. Therefore, it fits the category of a Call Transcript announcement or invitation. Since it is an invitation to a conference call, the appropriate classification is Call Transcript (CT).
2023-02-08 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is dated 8th February 2023 and is addressed to stock exchanges, indicating a regulatory filing. It announces the outcome of a Board Meeting held on the same date, specifically the approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December 2022. The document includes detailed financial data such as income, expenses, segment results, and notes on exceptional items. It also contains an Independent Auditor's Review Report on these unaudited quarterly financial results pursuant to SEBI regulations. The presence of unaudited quarterly and nine-month financial results with substantive financial data and analysis confirms this is an Interim / Quarterly Report. The document is about quarterly and nine-month financial results, not a full annual report or just an announcement of a report. Therefore, the correct classification is Interim / Quarterly Report (IR).
2023-02-08 English
Further to our letter dated 1st February, 2023 and pursuant to Regulation 30 and Schedule llI of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), ....
Interim / Quarterly Report Classification · 100% confidence The document is dated 8th February 2023 and is addressed to stock exchanges, indicating a regulatory filing. It announces the outcome of a Board Meeting held on the same date, specifically the approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December 2022. The document includes detailed financial data such as income, expenses, segment results, and notes, as well as an Independent Auditor's Review Report on these unaudited quarterly financial results. The presence of unaudited quarterly and nine-month financial results with substantive financial data and analysis confirms this is an Interim / Quarterly Report. It is not a mere announcement or certification but contains actual financial statements and auditor review, fitting the definition of an Interim / Quarterly Report (IR).
2023-02-08 English
Further to our letter dated 1st February, 2023 and pursuant to Regulation 30 and Schedule llI of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), ....
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement dated 8th February 2023 from India Glycols Limited addressed to stock exchanges, reporting the outcome of a Board Meeting held on the same day. It includes unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December 2022, along with limited review reports from statutory auditors. The document contains comprehensive financial data including income, expenses, segment results, and notes explaining exceptional items and other financial details. The presence of detailed financial statements and auditor's review indicates this is a quarterly financial report rather than a brief announcement or certification. The document is about unaudited quarterly financial results and year-to-date results, which fits the definition of an Interim / Quarterly Report (IR).
2023-02-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.